Jurgen Wolf

Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis: Analysis of Data From the Histology-Independent, Phase 2, Open-label VE-BASKET Study

J. Blay, J. Baselga, O. Abdel-Wahab, 2017, JAMA oncology.